• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房中的肾脏替代治疗方式与技术:一项国际调查。

Renal replacement therapy modalities and techniques in intensive care units: An international survey.

作者信息

Monard Céline, Marel Arnaud, Joannidis Michael, Ostermann Marlies, Peng Zhiyong, Doi Kent, De Rosa Silvia, Bobek Ilona, Sokolov Dmitry, Wu Vin-Cent, Premuzic Vedran, Mehta Ravindra, Bellomo Rinaldo, Garcia Xaime, Pizarro Camilo, Zarbock Alexander, Milet Igor, Reis Thiago, Romain Marc, Mc Nicholas Bairbre, Schneider Antoine, Rimmelé Thomas

机构信息

Service d'anesthésie-réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Service de Médecine Intensive Adulte, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; EA 7426, Pathophysiology of Injury-Induced Immunosuppression, Hospices Civils de Lyon-Biomérieux-Université Claude Bernard Lyon 1, Lyon, France.

Service d'anesthésie-réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

出版信息

J Crit Care. 2025 Aug;88:155076. doi: 10.1016/j.jcrc.2025.155076. Epub 2025 Apr 3.

DOI:10.1016/j.jcrc.2025.155076
PMID:40179459
Abstract

BACKGROUND AND HYPOTHESIS

Up to 14 % of critically ill patients receive renal replacement therapy (RRT) during their ICU stay and are treated with intermittent hemodialysis (IHD) or one of the continuous renal replacement therapy (CRRT) techniques. The choice of a modality (IHD or CRRT) and technique (continuuous veno-venous -hemodialysis (CVVHD), -hemofiltration (CVVH), or - hemodiafiltration (CVVHDF)), and the way it is delivered, may have an impact on outcomes but only few studies addressed this question. We aimed to survey the availability, settings, and clinicians' preferences regarding RRT modalities and techniques in critically ill patients.

METHODS

Between July 2021 and March 2022, we conducted an open online worldwide survey targeting ICU clinicians and consisting of 31 questions.

RESULTS

Among the 1174 participants from 73 countries, 94 % indicated their ability to initiate RRT at any time. CRRT was more widely available than IHD (97 % vs 85 %). CVVHDF was the most frequently used CRRT technique (59 %), followed by CVVHD (26 %) and CVVH (16 %). Most participants (70 %) reported having access to at least two CRRT techniques in their unit. Preference for IHD or CRRT varied greatly, depending on the clinical situation. Among CRRT techniques, CVVHD was preferred for removal of small-sized molecules, better hemofilter lifespan and reduced nursing workload. The preferential indications for CVVH included septic shock, removal of middle-sized molecules and fluid overload. The technical settings for CVVH and CVVHDF were very heterogeneous.

CONCLUSION

This international survey underscores the large diversity in RRT practices wordlwide, as well as heterogeneity in beliefs and preferences among intensivists. These data highlight the need for robust comparative trials to identify the optimal RRT modality and technique to improve outcomes in specific clinical situations.

摘要

背景与假设

高达14%的重症患者在重症监护病房(ICU)住院期间接受肾脏替代治疗(RRT),并采用间歇性血液透析(IHD)或连续性肾脏替代治疗(CRRT)技术之一进行治疗。治疗方式(IHD或CRRT)和技术(连续性静脉 - 静脉血液透析(CVVHD)、血液滤过(CVVH)或血液透析滤过(CVVHDF))的选择及其实施方式可能会对治疗结果产生影响,但只有少数研究探讨了这个问题。我们旨在调查重症患者RRT方式和技术的可用性、设置情况以及临床医生的偏好。

方法

在2021年7月至2022年3月期间,我们针对ICU临床医生开展了一项全球范围内的开放式在线调查,该调查包含31个问题。

结果

在来自73个国家的1174名参与者中,94%表示他们能够随时启动RRT。CRRT比IHD更广泛可用(97%对85%)。CVVHDF是最常用的CRRT技术(59%),其次是CVVHD(26%)和CVVH(16%)。大多数参与者(70%)报告称其所在科室至少可使用两种CRRT技术。对IHD或CRRT的偏好因临床情况而异。在CRRT技术中,CVVHD因能清除小分子物质、具有更长的血液滤过器使用寿命以及减少护理工作量而更受青睐。CVVH的优先适应证包括感染性休克、清除中分子物质和液体超负荷。CVVH和CVVHDF的技术设置非常多样化。

结论

这项国际调查强调了全球范围内RRT实践的巨大差异,以及重症医学专家在观念和偏好上的异质性。这些数据凸显了开展有力的对比试验以确定最佳RRT方式和技术从而改善特定临床情况下治疗结果的必要性。

相似文献

1
Renal replacement therapy modalities and techniques in intensive care units: An international survey.重症监护病房中的肾脏替代治疗方式与技术:一项国际调查。
J Crit Care. 2025 Aug;88:155076. doi: 10.1016/j.jcrc.2025.155076. Epub 2025 Apr 3.
2
Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.初始肾脏替代治疗(RRT)方式与危重症急性肾损伤(AKI)幸存者出院后90天的RRT依赖相关。
J Crit Care. 2024 Aug;82:154764. doi: 10.1016/j.jcrc.2024.154764. Epub 2024 Mar 8.
3
The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI).剂量反应多中心国际合作倡议(DO-RE-MI)
Contrib Nephrol. 2007;156:434-43. doi: 10.1159/000102137.
4
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.连续性肾脏替代治疗与间歇性血液透析作为严重急性肾损伤肾脏替代治疗的一线治疗方法比较:AKIKI 和 IDEAL-ICU 研究的二次分析。
Crit Care. 2022 Apr 4;26(1):93. doi: 10.1186/s13054-022-03955-9.
5
Comparison of unplanned treatment interruption during CRRT in ICU patients under CVVH (pre + post dilution) or CVVHDF (post-dilution) mode: A retrospective cohort study.ICU患者在持续静静脉血液滤过(前稀释+后稀释)或持续静静脉血液透析滤过(后稀释)模式下进行连续性肾脏替代治疗期间计划外治疗中断的比较:一项回顾性队列研究。
Nurs Crit Care. 2025 Mar;30(2):e70025. doi: 10.1111/nicc.70025.
6
Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.加速静脉-静脉血液滤过在重症监护病房作为过渡性肾脏替代治疗。
Am J Nephrol. 2020;51(4):318-326. doi: 10.1159/000506412. Epub 2020 Feb 25.
7
Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy?重症监护病房中的肾脏替代治疗:间歇性血液透析、持续低效透析或连续性肾脏替代治疗?
Curr Opin Crit Care. 2018 Dec;24(6):437-442. doi: 10.1097/MCC.0000000000000541.
8
Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.评估肾脏替代治疗方式的选择对严重急性肾衰竭预后的影响。
Clin Nephrol. 2005 May;63(5):335-45. doi: 10.5414/cnp63335.
9
Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control.将急性肾衰竭的治疗从间歇性血液透析改为连续性血液滤过:对氮质血症控制的影响。
Int J Artif Organs. 1999 Mar;22(3):145-50.
10
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.接受肾脏替代治疗患者抗菌治疗的药代动力学考量
Clin Pharmacokinet. 2007;46(12):997-1038. doi: 10.2165/00003088-200746120-00003.

引用本文的文献

1
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.美罗培南和哌拉西林/他唑巴坦用于接受肾脏替代治疗的重症患者的优化给药方案。
Intensive Care Med. 2025 Aug 13. doi: 10.1007/s00134-025-08067-w.